Literature DB >> 31044659

Guidelines Are Not Gospel!

Gilbert H Daniels1, Peter A Kopp2.   

Abstract

Entities:  

Mesh:

Year:  2019        PMID: 31044659      PMCID: PMC8881947          DOI: 10.1089/thy.2019.0283

Source DB:  PubMed          Journal:  Thyroid        ISSN: 1050-7256            Impact factor:   6.568


× No keyword cloud information.
  37 in total

1.  Adjuvant post-operative I-131 therapy in differentiated thyroid carcinoma: are the 2015 ATA guidelines an exact science or a dark art?

Authors:  Frederik A Verburg; Markus Luster; Luca Giovanella
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-02       Impact factor: 9.236

2.  I-131 as adjuvant treatment for differentiated thyroid carcinoma may cause an increase in the incidence of secondary haematological malignancies: an "inconvenient" truth?

Authors:  Frederik A Verburg; Luca Giovanella; Ioannis Iakovou; Mark W Konijnenberg; Werner Langsteger; Michael Lassmann; Jasna Mihailovic; Markus Luster
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-10-08       Impact factor: 9.236

3.  Comparison of Empiric Versus Whole-Body/-Blood Clearance Dosimetry-Based Approach to Radioactive Iodine Treatment in Patients with Metastases from Differentiated Thyroid Cancer.

Authors:  Désirée Deandreis; Carole Rubino; Hernan Tala; Sophie Leboulleux; Marie Terroir; Eric Baudin; Steve Larson; James A Fagin; Martin Schlumberger; R Michael Tuttle
Journal:  J Nucl Med       Date:  2016-10-13       Impact factor: 10.057

4.  Radioactive Iodine-Related Clonal Hematopoiesis in Thyroid Cancer Is Common and Associated With Decreased Survival.

Authors:  Laura Boucai; John Falcone; Jenny Ukena; Catherine C Coombs; Ahmet Zehir; Ryan Ptashkin; Michael F Berger; Ross L Levine; James A Fagin
Journal:  J Clin Endocrinol Metab       Date:  2018-11-01       Impact factor: 5.958

5.  Comparison of Performance Characteristics of American College of Radiology TI-RADS, Korean Society of Thyroid Radiology TIRADS, and American Thyroid Association Guidelines.

Authors:  William D Middleton; Sharlene A Teefey; Carl C Reading; Jill E Langer; Michael D Beland; Margaret M Szabunio; Terry S Desser
Journal:  AJR Am J Roentgenol       Date:  2018-04-09       Impact factor: 3.959

6.  Small-molecule MAPK inhibitors restore radioiodine incorporation in mouse thyroid cancers with conditional BRAF activation.

Authors:  Debyani Chakravarty; Elmer Santos; Mabel Ryder; Jeffrey A Knauf; Xiao-Hui Liao; Brian L West; Gideon Bollag; Richard Kolesnick; Tin Htwe Thin; Neal Rosen; Pat Zanzonico; Steven M Larson; Samuel Refetoff; Ronald Ghossein; James A Fagin
Journal:  J Clin Invest       Date:  2011-11-21       Impact factor: 14.808

7.  Decreasing Use of Radioactive Iodine for Low-Risk Thyroid Cancer in California, 1999 to 2015.

Authors:  Ki Wan Park; James X Wu; Lin Du; Angela M Leung; Michael W Yeh; Masha J Livhits
Journal:  J Clin Endocrinol Metab       Date:  2018-03-01       Impact factor: 5.958

8.  An analysis of "ablation of thyroid remnants" with I-131 in 511 patients from 1947-1984: experience at University of Michigan.

Authors:  W H Beierwaltes; R Rabbani; C Dmuchowski; R V Lloyd; P Eyre; S Mallette
Journal:  J Nucl Med       Date:  1984-12       Impact factor: 10.057

9.  Selumetinib-enhanced radioiodine uptake in advanced thyroid cancer.

Authors:  Alan L Ho; Ravinder K Grewal; Rebecca Leboeuf; Eric J Sherman; David G Pfister; Desiree Deandreis; Keith S Pentlow; Pat B Zanzonico; Sofia Haque; Somali Gavane; Ronald A Ghossein; Julio C Ricarte-Filho; José M Domínguez; Ronglai Shen; R Michael Tuttle; Steve M Larson; James A Fagin
Journal:  N Engl J Med       Date:  2013-02-14       Impact factor: 91.245

Review 10.  Papillary and follicular thyroid cancer: selective therapy.

Authors:  E L Mazzaferri
Journal:  Compr Ther       Date:  1981-05
View more
  1 in total

1.  Radioiodine remnant ablation in stage I adult papillary thyroid carcinoma: does it improve postoperative outcome?

Authors:  Ian D Hay; Suneetha Kaggal; Geoffrey B Thompson
Journal:  Eur Thyroid J       Date:  2022-07-12
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.